SummerHaven Investment Management LLC Invests $1.23 Million in Varex Imaging $VREX

SummerHaven Investment Management LLC bought a new stake in Varex Imaging (NASDAQ:VREX) during the third quarter, Holdings Channel reports. The fund bought 99,431 shares of the company’s stock, valued at approximately $1,233,000. Varex Imaging comprises about 0.7% of SummerHaven Investment Management LLC’s investment portfolio, making the stock its 7th biggest position.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bailard Inc. acquired a new position in shares of Varex Imaging in the 3rd quarter valued at about $479,000. State of Alaska Department of Revenue purchased a new stake in Varex Imaging during the third quarter worth approximately $27,000. Rice Hall James & Associates LLC increased its position in shares of Varex Imaging by 20.8% in the third quarter. Rice Hall James & Associates LLC now owns 909,261 shares of the company’s stock worth $11,275,000 after acquiring an additional 156,289 shares in the last quarter. Inspire Investing LLC acquired a new stake in shares of Varex Imaging in the third quarter worth $461,000. Finally, Assenagon Asset Management S.A. raised its stake in shares of Varex Imaging by 166.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 296,128 shares of the company’s stock valued at $3,672,000 after acquiring an additional 184,959 shares during the period.

Wall Street Analysts Forecast Growth

VREX has been the subject of a number of research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research report on Monday, December 29th. B. Riley reaffirmed a “buy” rating and issued a $16.00 target price on shares of Varex Imaging in a research report on Wednesday, November 19th. Wall Street Zen upgraded Varex Imaging from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 22nd. Finally, Oppenheimer reduced their price target on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Varex Imaging presently has a consensus rating of “Hold” and an average price target of $17.00.

Varex Imaging Stock Up 0.9%

Shares of NASDAQ VREX opened at $14.08 on Wednesday. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $15.46. The firm has a market cap of $590.23 million, a price-to-earnings ratio of -8.28 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.83 and a current ratio of 3.43. The stock’s 50-day simple moving average is $12.26 and its 200-day simple moving average is $11.30.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings data on Tuesday, November 18th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.19. The company had revenue of $228.90 million for the quarter, compared to the consensus estimate of $219.26 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%.Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. As a group, equities analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.